223 related articles for article (PubMed ID: 9354207)
1. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
Armbrecht U; Abucar A; Hameeteman W; Schneider A; Stockbrügger RW
Aliment Pharmacol Ther; 1997 Oct; 11(5):959-65. PubMed ID: 9354207
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
[TBL] [Abstract][Full Text] [Related]
3. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
Adamek RJ; Behrendt J; Wenzel C
Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):811-7. PubMed ID: 11474311
[TBL] [Abstract][Full Text] [Related]
4. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
5. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
Koop H; Schepp W; Dammann HG; Schneider A; Lühmann R; Classen M
J Clin Gastroenterol; 1995 Apr; 20(3):192-5. PubMed ID: 7797824
[TBL] [Abstract][Full Text] [Related]
6. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
Dettmer A; Vogt R; Sielaff F; Lühmann R; Schneider A; Fischer R
Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
Kovacs TO; Wilcox CM; DeVault K; Miska D; Bochenek W;
Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.
van Rensburg CJ; Honiball PJ; Grundling HD; van Zyl JH; Spies SK; Eloff FP; Simjee AE; Segal I; Botha JF; Cariem AK; Marks IN; Theron I; Bethke TD
Aliment Pharmacol Ther; 1996 Jun; 10(3):397-401. PubMed ID: 8791969
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of pantoprazole compared with ranitidine.
Bader JP; Delchier JC
Aliment Pharmacol Ther; 1994; 8 Suppl 1():47-52. PubMed ID: 8180294
[TBL] [Abstract][Full Text] [Related]
10. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
Mössner J; Koop H; Porst H; Wübbolding H; Schneider A; Maier C
Aliment Pharmacol Ther; 1997 Dec; 11(6):1087-92. PubMed ID: 9663834
[TBL] [Abstract][Full Text] [Related]
11. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
Holtmann G; Cain C; Malfertheiner P
Gastroenterology; 1999 Jul; 117(1):11-6. PubMed ID: 10381904
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease.
Robinson M; Maton PN; Rodriguez S; Greenwood B; Humphries TJ
Aliment Pharmacol Ther; 1997 Oct; 11(5):973-80. PubMed ID: 9354209
[TBL] [Abstract][Full Text] [Related]
13. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
[TBL] [Abstract][Full Text] [Related]
14. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial.
Mössner J; Hölscher AH; Herz R; Schneider A
Aliment Pharmacol Ther; 1995 Jun; 9(3):321-6. PubMed ID: 7654895
[TBL] [Abstract][Full Text] [Related]
15. Prevention of erosive oesophagitis relapse with pantoprazole.
Richter JE; Fraga P; Mack M; Sabesin SM; Bochenek W;
Aliment Pharmacol Ther; 2004 Sep; 20(5):567-75. PubMed ID: 15339328
[TBL] [Abstract][Full Text] [Related]
16. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis.
Netzer P; Gut A; Brundler R; Gaia C; Halter F; Inauen W
Aliment Pharmacol Ther; 2001 Sep; 15(9):1375-84. PubMed ID: 11552908
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial.
Mulder CJ; Westerveld BD; Smit JM; Oudkerk Pool M; Otten MH; Tan TG; van Milligen de Wit AW; de Groot GH;
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):649-56. PubMed ID: 12072599
[TBL] [Abstract][Full Text] [Related]
18. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.
Corinaldesi R; Valentini M; Belaïche J; Colin R; Geldof H; Maier C
Aliment Pharmacol Ther; 1995 Dec; 9(6):667-71. PubMed ID: 8824655
[TBL] [Abstract][Full Text] [Related]
19. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
20. The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery.
Memiş D; Turan A; Karamanlioglu B; Saral P; Türe M; Pamukçu Z
Anesth Analg; 2003 Nov; 97(5):1360-1363. PubMed ID: 14570652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
